AstraZeneca
AstraZeneca’s Bruno Angelici awarded Légion d`honneur
January 8, 2010Sales and Marketing AstraZeneca, France, appointment, sales and marketing
AstraZeneca’s Bruno Angelici has been appointed Chevalier dans l`Ordre National de la Légion d`honneur in the French New Year honours …
AstraZeneca signs deals to increase anti-infective portfolio
January 7, 2010Research and Development, Sales and Marketing AstraZeneca, Forest, Novexel
AstraZeneca is to buy infection research firm Novexel for $350 million. The manufacturer will take all the French company’s shares …
AstraZeneca’s Chris Brinsmead and ex-health minister Lord Darzi appointed ambassadors for UK lifescience
December 15, 2009Research and Development, Sales and Marketing AstraZeneca, Darzi, UK, appointment, research and development, sales and marketing
AstraZeneca UK’s chairman Chris Brinsmead and former health minister Lord Ara Darzi are among six newly appointed private sector business …
Dr Jan Lundberg to succeed Dr Steven Paul as head of Lilly Research Laboratories
November 27, 2009Research and Development AstraZeneca, appointment, appt, lilly, research and development
Dr Jan Lundberg has been appointed executive VP, science and technology, and president of Lilly Research Laboratories.He will succeed Dr …
Digital Pharma: AstraZeneca joins the blogosphere
November 26, 2009Medical Communications AstraZeneca, blog, digi, digital pharma
AstraZeneca recently launched its first official corporate blog, joining the likes of Johnson & Johnson and
Digital Pharma: Reacting to sidewiki
November 18, 2009Medical Communications AstraZeneca, digi, digital pharma, google, sidewiki
Over the last two months pharmaceutical company websites have been plagued by unwanted, un-moderated comments thanks to Google’s sidewiki.The search …
AstraZeneca’s AZD3480 progresses in ADHD
July 11, 2009Sales and Marketing ADHD, Alzheimer's, Alzheimer's ADHD, AstraZeneca
AstraZeneca is to progress its AZD3480 (TC-1734) for attention deficit/hyperactivity disorder (ADHD) and has agreed to make a $10 million …
AstraZeneca and Merck launch early stage trial collaboration
June 3, 2009Research and Development AZ, AstraZeneca, Cancer, Merck
Merck and AstraZeneca have begun an unprecedented collaboration to bring together the clinical trials of two early stage cancer medicines.The …
Working Life: Les Hughes
January 8, 2009Research and Development AstraZeneca, Cancer, clinical research, infection
How did you find your way into your role? I wanted to be a chemist from my very first experience …
The Pharmafocus Interview: Jan Lundberg
October 10, 2008Research and Development AstraZeneca, clinical trials, drug discover
AstraZeneca's head of global drug discovery Jan Lundberg says his younger years as a sportsman have made him a determined …
AstraZeneca signs Singapore cancer research deal
August 15, 2008Research and Development AstraZeneca, Singapore, emerging markets
AstraZeneca has signed a deal to work with Singapore’s National Cancer Centre and National University Hospital to develop new cancer …
Groundbreaking pharma-NHS collaboration launched in Nottingham
May 30, 2008ABPI, ABPI Outreach Programme, AstraZeneca, Boehringer Ingelheim, COPD, GlaxoSmithKline, INFORCE, Nottingham, Nycomed, Pfizer, joint working
A group of pharmaceutical companies have joined forces with Nottingham healthcare services to help improve care for patients with chronic …
The Pharmafocus Interview: John Patterson
December 19, 2007Research and Development, Sales and Marketing AstraZeneca, drug development, industry relations
John Patterson is an AstraZeneca man through-and-through, having spent nearly all his working life at the company. But over the …
Trading Places
March 9, 2007Business Services, Medical Communications, Sales and Marketing AstraZeneca, Athena, public relations, recruitment
Athena Medical PR and AstraZeneca UK have joined forces to undertake a ground-breaking secondment initiative to help build broader expertise …
AZ sales hit by launch of generic Toprol
November 30, 2006Sales and Marketing AstraZeneca
AstraZeneca's share prices took a dip after news that the company's end-of-year sales figures would be lower than predicted. These …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
